Skip to Main Content

Paper Details

Detection rate of actionable mutations in diverse cancers using a biopsy-free (blood) circulating tumor cell DNA assay.
Oncotarget
114
2016
Author NameAffiliation
Paul T FantaCenter for Personalized Cancer Therapy and Division of Hematology and Oncology, university of california san diego Moores Cancer Center
Richard B SchwabCenter for Personalized Cancer Therapy and Division of Hematology and Oncology, university of california san diego Moores Cancer Center
AmirAli TalasazInc.
  • 1 - 3

Datasets

Release 1.2